MicroRNA-384 is lowly expressed in human prostate cancer cells and has anti-tumor functions by acting on HOXB7

ConclusionMiR-384 was downregulated in CAP cells. MiR-384 overexpression suppressed CAP in vitro and in vivo development, possibly via acting through its downstream target gene of HOXB7.
Source: Biomedicine and Pharmacotherapy - Category: Drugs & Pharmacology Source Type: research